UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that the Centers for ...
UroGen Pharma (URGN) announced that the Centers for Medicare and Medicaid Services, CMS, has assigned a permanent Healthcare Common Procedure ...
Nearly every major health system has adopted, or is adopting, ambient AI for clinical documentation––a rate of uptake more reminiscent of viral ...
Ambulatory surgery centers (ASCs) are increasingly important to health systems’ long-term growth strategies. ASC partnerships or purchases can increase a health system’s revenue and capacity and ...
Nearly two decades after the first statewide interoperability plan, the need for governance, standardized procedures, and ...
Elevation Spine’s Saber-C earned FDA clearance for two-level cervical spinal fusion, according to an Oct. 23 LinkedIn post. Saber-C can be used adjacent spine levels and has a zero-profile design. The ...
This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback